Related references
Note: Only part of the references are listed.Hepatitis C Virus Clearance in Older Adults
Antonio Massimo Ippolito et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients
Feng Su et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis
Antonio Ciaccio et al.
LIVER INTERNATIONAL (2017)
Superiority of Interferon-Free Regimens for Chronic Hepatitis C The Effect on Health-Related Quality of Life and Work Productivity
Zobair M. Younossi et al.
MEDICINE (2017)
Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C
Masanori Atsukawa et al.
DIGESTIVE AND LIVER DISEASE (2017)
Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease
Sabela Lens et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt
Naglaa F. A. Youssef et al.
BMC GASTROENTEROLOGY (2017)
The efficacy and safety of direct acting antiviral treatment and clinical significance of drug-drug interactions in elderly patients with chronic hepatitis C virus infection
J. Vermehren et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
An In-Depth Analysis of Patient-Reported Outcomes in Patients With Chronic Hepatitis C Treated With Different Anti-Viral Regimens
Zobair M. Younossi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Subjects Aged 65 Years or Older
Sammy Saab et al.
HEPATOLOGY (2016)
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
Graham R. Foster et al.
JOURNAL OF HEPATOLOGY (2016)
Patient-Reported Outcomes of Elderly Adults with Chronic Hepatitis C Treated with Interferon- and Ribavirin-Free Regimens
Zobair M. Younossi et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2013
E. H. Teshale et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States
Pegah Golabi et al.
MEDICINE (2016)
Predicting risk of adverse drug reactions in older adults
Amanda Hanora Lavan et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2016)
Value of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic Evidence
Roberto Nuno Solinis et al.
INFECTIOUS DISEASES AND THERAPY (2016)
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson et al.
HEPATOLOGY (2015)
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens
Umberto Vespasiani-Gentilucci et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
Maxine M. Denniston et al.
ANNALS OF INTERNAL MEDICINE (2014)
Patient-Reported Outcomes in Chronic Hepatitis C Patients With Cirrhosis Treated With Sofosbuvir-Containing Regimens
Zobair M. Younossi et al.
HEPATOLOGY (2014)
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H. Razavi et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Treatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin
Jordan J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kris V. Kowdley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
Aging and Chronic Kidney Disease
Kosaku Nitta et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2013)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Assessment of risk for non-hepatic surgery in cirrhotic patients
Prashant Bhangui et al.
JOURNAL OF HEPATOLOGY (2012)
Sustained Virological Response Reduces Incidence of Onset of Type 2 Diabetes in Chronic Hepatitis C
Yasuji Arase et al.
HEPATOLOGY (2009)
Progression to cirrhosis in hepatitis C patients:: an age-dependent process
Pierre Pradat et al.
LIVER INTERNATIONAL (2007)
Hepatitis C in 6,865 patients 65 yr or older: A severe and neglected curable disease?
Dominique Thabut et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Gregory L. Armstrong et al.
ANNALS OF INTERNAL MEDICINE (2006)
Anemia in the elderly - Clinical findings and impact on health
L. Balducci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C?
A Floreani et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2006)
Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C
C. G. Nudo et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2005)
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
D Bernstein et al.
HEPATOLOGY (2002)
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C
T Poynard et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
